Expanding the treatment options for HER2-low metastatic breast cancer: Experience with trastuzumab deruxtecan in aggressive luminal HER2-low breast cancer

E. V. Lubennikova; I. P. Ganshina; M. Sh. Manukyan; I. E. Tyurin; E. V. Artamonova

Meditsinskiy sovet = Medical Council
Meditsinskiy sovet

ISSN 2079-701X (Print)
ISSN 2658-5790 (Online)

User

eng | рус

Meditsinskiy sovet = Medical Council

Advanced search

Archives

Download this PDF file

Fullscreen

For citations:

Lubennikova EV, Ganshina IP, Manukyan MS, Tyurin IE, Artamonova EV. Expanding the treatment options for HER2-low metastatic breast cancer: Experience with trastuzumab deruxtecan in aggressive luminal HER2-low breast cancer. Meditsinskiy sovet = Medical Council. 2024;(10):66-73. (In Russ.) https://doi.org/10.21518/ms2024-246

Views PDF (Rus): 151

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 2079-701X (Print)
ISSN 2658-5790 (Online)

Editor-in-Chief

Aydar A. Ishmukhametov

* not an advertisement

По рекомендации Президиума ВАК от 8 декабря 2023 г. № 31/1-разн

"О категорировании перечня рецензируемых научных изданий, в которых должны быть опубликованы основные научные результаты диссертаций на соискание ученой степени кандидата наук, на соискание ученой степени доктора наук" журналу «Медицинский совет» присвоена категория К1

Popular articles

Indexing Databases

* not an advertisement

Article Tools

Finding References

Email this article (Login required)

Email the author (Login required)

About the Authors

E. V. Lubennikova
Blokhin National Medical Research Center of Oncology
Russian Federation

Elena V. Lubennikova - Cand. Sci. (Med.), Senior Researcher at the Department of Antitumor Drug Therapy No. 1 with a Day Hospital of the Department of Drug Treatment of the Scientific Research Institute of Clinical Oncology named after N.N. Trapeznikov.

23, Kashirskoye Shosse, Moscow, 115478

I. P. Ganshina
Blokhin National Medical Research Center of Oncology
Russian Federation

Inna P. Ganshina - Cand. Sci. (Med.), Leading Researcher at the Department of Antitumor Drug Therapy No. 1 with a Day Hospital of the Department of Drug Treatment of the Scientific Research Institute of Clinical Oncology named after N.N. Trapeznikov.

23, Kashirskoye Shosse, Moscow, 115478

M. Sh. Manukyan
Blokhin National Medical Research Center of Oncology
Russian Federation

Mariam Sh. Manukyan - Oncologist of the Oncology Department of Antitumor Drug Therapy No. 2 with a Day Hospital of the Department of Drug Treatment of the Scientific Research Institute of Clinical Oncology named after N.N. Trapeznikov.

23, Kashirskoye Shosse, Moscow, 115478

I. E. Tyurin
Blokhin National Medical Research Center of Oncology
Russian Federation

Igor E. Tyurin - Dr. Sci. (Med.), Professor, Deputy Director for Science, Research Institute of Clinical and Experimental Oncology.

23, Kashirskoye Shosse, Moscow, 115478

E. V. Artamonova
Blokhin National Medical Research Center of Oncology; Pirogov Russian National Research Medical University; Moscow Regional Research Clinical Institute named after M.F. Vladimirsky
Russian Federation

Elena V. Artamonova - Dr. Sci. (Med.), Professor of the Department of Oncology and Radiation Therapy, Pirogov RNRMU; Head of the Department of Oncology and Thoracic Surgery, MRRCI named after M.F. Vladimirsky Head of the Department of Antitumor Drug Therapy No. 1 with a day hospital of the Department of Drug Treatment of the Scientific Research Institute of Clinical Oncology named after. N.N. Trapeznikov, Blokhin NMRCO.

1, Ostrovityanov St., Moscow, 117997; 61/2, Bldg. 1, Schepkin St., Moscow, 129110; 23, Kashirskoye Shosse, Moscow, 115478

Notifications

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Meditsinskiy sovet = Medical Council

For citations:

Cookies policy